tci Medicare Compliance & Reimbursement - 2022 Issue Q2
Enforcement: Feds Double Down Scrutiny of COVID Fraud
Subscribe or sign in to view the full article.
Article Overview
This article summarizes a recent HHS Office of Inspector General semiannual report and highlights how federal enforcement priorities have centered on COVID-19-related fraud and abuse. It is relevant to compliance teams, auditors, coders, billing staff, and healthcare leaders who track fraud enforcement activity affecting Medicare and other federal healthcare programs. The article also reviews several high-profile Medicare fraud cases involving home health, durable medical equipment, and laboratory testing/telemedicine-related schemes, along with broad enforcement statistics and recovery figures.
Why This Topic Matters
The article helps readers understand current enforcement focus areas that may affect compliance monitoring, billing oversight, and fraud risk assessment in healthcare organizations participating in federal programs.
Article Sections
-
Background
Introduces the OIG semiannual reporting framework and explains the broad enforcement focus during the reporting period, with emphasis on COVID-19 response and recovery efforts.
-
Statistics
Summarizes the report’s enforcement and recovery totals, including audits, evaluations, investigations, criminal and civil actions, and exclusions.
-
Critical
Describes the report’s Medicare-related concerns tied to COVID-19 testing trends and broader laboratory spending patterns.
-
Check Out These Top Medicare Enforcement Cases
Introduces a set of notable Medicare fraud matters highlighted in the report, spanning multiple areas of alleged misconduct.
-
Home health
Covers a major home health fraud case referenced in the report, including the enforcement outcome and related fugitive history.
-
DME
Reviews a durable medical equipment fraud case involving Medicare claims, financial losses, and criminal sentencing.
-
Lab testing
Summarizes a laboratory testing and telemedicine-related Medicare fraud scheme discussed in the report.
What You Will Learn
- How the OIG framed its enforcement priorities during the reporting period
- What types of healthcare fraud cases were emphasized in the report
- How the article characterizes COVID-19’s role in federal fraud scrutiny
- Which broad categories of Medicare-related schemes were highlighted
- What enforcement and recovery activity the OIG reported during the period
Who Should Read This
- Healthcare compliance professionals
- Medical billing and coding staff
- Revenue cycle teams
- Healthcare auditors
- Practice administrators
- Hospital and health system leaders
- Fraud and abuse investigators
Subscribe or sign in to view the full article.
Thank you for choosing Find-A-Code, please Sign In to remove ads.



Quick, Current, Complete - www.findacode.com